Compare Stryker Corporation (SYK) vs Verizon Communications Inc (VZ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Stryker Corporation vs Verizon Communications Inc — how do they compare? Stryker Corporation trades at $277.33 (market cap $106.24B), while Verizon Communications Inc trades at $41.65 (market cap $192.57B). The key difference: Verizon Communications Inc is the larger of the two by market cap, and Verizon Communications Inc pays the higher dividend (6.11%). Which is the better fit depends on your goals — on Pluang, investors hold Stryker Corporation for 21 Days and Verizon Communications Inc for 109 Days on average.
| SYK | VZ | |
|---|---|---|
Market Cap | $106.24B | $192.57B |
Volume | 2,982,001 | 20,940,094 |
Sector | Health | Media |
52-Week High | $388.35 | $51.45 |
52-Week Low | $269.75 | $38.40 |
Typical Hold Time | 21 Days | 109 Days |
Enterprise Value | $117.70B | $379.28B |
Dividend Yield | 1.27% | 6.11% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Stryker (SYK) trades at $277.33, up 0.7% on the day, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279, while fundamentals remain solid with a 14.43% net income margin and strong analyst consensus. Recent news highlights ongoing legal scrutiny related to a manufacturing issue disclosed in September 2026, which caused an 8.8% stock drop, but the company continues to innovate with product launches like Prophecy surgical planning.
The outlook for SYK is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities include robust profitability and growth in medical technology, but risks persist from legal investigations and potential operational disruptions. Investors should weigh strong analyst support against near-term sentiment headwinds.
Verizon (VZ) trades at $46.35, up 1.27% today, with a bearish technical signal but strong fundamentals including a P/E of 12.07 and net income margin of 11.64%. Recent earnings beats and a $0.71 dividend highlight stability, while cash flow improved to $14.86B in 2025. The stock is near its consensus price target of $48.17, with analyst sentiment mixed but leaning hold.
Outlook: Verizon offers value with steady dividends and cash flow, but faces competition and debt risks. Upside depends on execution in wireless markets; cautious optimism is warranted given technical weakness and modest growth projections.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →About Verizon Communications Inc
Verizon Communications Inc. is an integrated telecommunications company that provides wire line voice and data services, wireless services, Internet services, and published directory information. The Company also provides network services for the federal government including business phone lines, data services, telecommunications equipment, and payphones.
Read more on VZ →
